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Open access under the ElSeveral epidemiological and experimental studies has been reported that lutein (LT) presents antioxidant
properties. Aim of the present study was to investigate the protective effects of LT against oxidative stress
and DNA damage induced by cisplatin (cDDP) in a human derived liver cell line (HepG2). Cell viability and
DNA-damage was monitored by MTT and comet assays. Moreover, different biochemical parameters
related to redox status (glutathione, cytochrome-c and intracellular ROS) were also evaluated. A clear
DNA-damage was seen with cDDP (1.0 lM) treatment. In combination with the carotenoid, reduction
of DNA damage was observed after pre- and simultaneous treatment of the cells, but not when the carot-
enoid was added to the cells after the exposure to cDDP. Exposure of the cells to cDDP also caused sig-
niﬁcant changes of all biochemical parameters and in co-treatment of the cells with LT, the carotenoid
reverted these alterations. The results indicate that cDDP induces pronounced oxidative stress in HepG2
cells that is related to DNA damage and that the supplementation with the antioxidant LT may protect
these adverse effects caused by the exposure of the cells to platinum compound, which can be a good pre-
dict for chemoprevention.
 2011 Elsevier Ltd.Open access under the Elsevier OA license.1. Introduction
Attention has been paid to plant foods and natural compounds
as a cost-effective approach to control chronic diseases related to
imbalance of redox status and genetic alterations. The typical hu-
man diet contains about 40 carotenoids, most of which are ob-
tained from fruits, vegetables and seafood (Gerster, 1997), such
as b-carotene, a-carotene, lycopene, lutein (LT) and zeaxanthin
(Parker, 1989). A highly promising candidate for the chemopreven-
tion of adverse health effects in humans is (LT), the second most
prevalent carotenoid in the human serum (Khachik et al., 1997)
which is present in abundance in dark, leafy green vegetables, such
as spinach and kale (Sommerburg et al., 1998).
The protective effects of LT have been poorly studied compared
to those of other carotenoids. For example, Santocono et al. (2006)
demonstrated the antioxidant properties of LT against DNA dam-
age induced by ultraviolet irradiation in human neuroblastoma
and rat trachea epithelial cell cultures. In another study, Santocono
et al. (2007) observed that LT was effective against the DNA-dam-
age induced by reactive nitrogen and oxygen species (RNS and ROS,x: +55 16 3602 4275.
elos).
sevier OA license.respectively) in a neuroblastoma cell line, but few conclusions
were drawn about the possible protective mechanisms involved.
Studies concerning LT protective effects against the crosslink for-
mation induced by cisplatin (cDDP) was done in vivo by our re-
search group (Serpeloni et al., 2010), however, in in vivo studies
is more difﬁcult to establish a clear relationship between the
parameters of oxidative stress and crosslink induction.
Therefore, aim of the present study was to evaluate the relation-
ship between antioxidant effects of LT and DNA crosslink induced
by cDDP, a known DNA-damage inducer that it is also able to cause
alterations of the redox status of the cells (Chirino and Pedraza-
Chaverri, 2009; Mendonça et al., 2010). Single cell gel electropho-
resis (SCGE) assays, which were used in the present investigation,
are based in the determination of DNAmigration in an electric ﬁeld
and are increasingly employed in genetic toxicology (Hoelzl et al.,
2009; Knasmuller et al., 2004). To draw conclusions, if the protec-
tive effects are due to mechanisms such as scavenging and induc-
tion of protective enzymes or to improvement of DNA-repair
processes, three different protocols were used, i.e., LT was added
to the cells before, during and after exposure to cDDP (pre-, simul-
taneous and post-treatment, respectively).
The experiments were carried out with a human derived liver
cell line (HepG2) which possesses a panel of enzymes that are
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the metabolism of xenobiotics better than other cell lines used in
routine testing (Knasmuller et al., 1998; Mersch-Sundermann
et al., 2004). Furthermore, viability of the cells were measured
by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT) assay and a number of biochemical parameters were deter-
mined, which reﬂect the redox status of the cells, namely glutathi-
one (GSH), cytochrome-c release (Cyt-c) and intracellular ROS. All
these parameters of cell viability, DNA damage and oxidative stress
were evaluated in order to clarify the mechanisms of protective ef-
fects of LT and its further possible application in chemoprevention.2. Materials and methods
2.1. Chemicals
LT (C40H56O2; CAS 127-40-2; purity > 95%) was donated by DSM
Nutritional Products (Basel, Switzerland). cDDP (CAS 15663-27-1)
was purchased from Quiral Química do Brasil (Juiz de Fora, Brazil).
Ethidium bromide (CAS 1239-45-8), trypan blue (CAS 72-57-1),
penicillin (CAS 61-33-6), streptomycin (CAS 57-92-1) and 2070-
dichloroﬂuorescein diacetate (H2DCFDA) (CAS 4091-99-0) were
purchased from Sigma–Aldrich (St Louis, MO, USA). Dulbecco’s
Modiﬁed Eagle Medium (DMEM), fetal bovine serum (FBS) and try-
pisin were purchased from Gibco (Carlsbad, CA, USA). Low melting
point agarose (CAS 9012-36-6) and normal melting point agarose
(CAS 9012-36-6) were dissolved in Ca2+ and Mg2+ free phosphate
buffer saline (PBS; pH 7.4) and came from Invitrogen (California,
CA, USA). All other chemicals were analytical grade products from
Sigma–Aldrich (St. Louis, MO, USA).2.2. Cell culture conditions and treatments
HepG2 cells were provided by S. Knasmüller (Institute of Cancer
Research – Medical University of Vienna, Austria). Stock cultures of
the cells (1.0 mL portions with 106 viable cells in DMEM with 15%
of FBS and 5% DMSO, respectively) were stored in liquid nitrogen.
For the experiments described in this study, the cells were de-
frosted and used between the 3rd and 8th passage. In all experi-
ments, the cells were cultivated for a complete cell cycle in
DMEM with 15% FBS and 1.0% of penicillin and streptomycin for
24 h in culture ﬂasks (75 cm2; Corning, Lowell, MA, USA) in 5%
CO2 atmosphere at 37 C and 96% of relative humidity. For sub-
cultivation, the cells were trypsinized, washed with PBS (pH 7.4),
centrifuged (1000 rpm, 5 min) and separated by pressing the sus-
pensions through a syringe (needle 0.4  19, Becton Dickinson,
São Paulo, Brazil).
To assess the impact of the carotenoid and of cDDP on cell via-
bility, the cells were exposed to LT (0.1, 1.0, 5.0, 10.0, 50.0 and
100.0 lM) and to cDDP (1.0, 5.0 and 10.0 lM) for the period of
24 h. Also, experiments which aimed to evaluate the association
of the carotenoid and the platinum compound were carried out.
i.e., LT (0.1–10.0 lM) was added for 24 h before (pre-treatment),
during (simultaneous treatment) or after (post-treatment) treat-
ment with cDDP (10.0 lM).
For SCGE assays, the three lowest non-cytotoxic concentrations
of the carotenoid, determined by the MTT assay, were used, i.e., 0.1,
1.0 and 10.0 lM and cDDP were used in the concentration of
1.0 lM. The cells were exposed to LT per se, before, during or after
the exposure to cDDP for the period of 3 h.
For determination of the biochemical parameters, cell lysates
were obtained by addition of sodium dodecyl sulfate solution at
0.1% in PBS (pH 7.4) by subsequent homogenization (30 rpm; Fa-
nem homogenizer, São Paulo, Brazil). The cell suspensions were
incubated at -4 C for 30 min and centrifuged at 1500 rpm for10 min. Subsequently, the supernatants were used for the assays,
which aimed to assess the biochemical parameters related to redox
status of the cells. HepG2 cells were cultivated and exposed to dif-
ferent concentrations of cDDP (0.01, 0.1, 0.5, 1.0, 5.0 and 10.0 lM)
for 3 h; a dose dependent curve was established with the concen-
tration of 1.0 lM of cDDP with different times of exposure (0.5, 1,
2, 4, 6, 12 and 24 h). Moreover, the cells were also treated with
cDPP (1.0 lM) in combination with several concentrations of the
carotenoid (0.1, 0.5, 1.0, 10.0 and 25.0 lM) for the period of 3 h.
Five independent cultures were made for each treatment in culture
ﬂasks for the three biochemical parameters evaluated.
In all experiments, solvent controls were included, i.e., LT and
cDDP were dissolved in a solution of DMSO (ﬁnal concentration
of 1% in PBS (pH 7.4)).
2.3. Cell viability assays
MTT assays were conducted as described by Mosmann (1983).
Absorbances at 570 nm were measured on a microenzyme-linked
immunoabsorbent assay (ELISA) reader (Sigma, São Paulo, Brazil).
Independent cultures were made in parallel in three different 96
well microplates to evaluate cell viability. For each culture (micro-
plate), the treatments were done in replicates (eight wells for
treatment in each microplate). Results of the experiments are ex-
pressed as percentage of viable cells (% of viable cells).
2.4. Single cell gel electrophoresis assays
SCGE assays were carried out according to the protocol of Uhl
et al. (1999). Brieﬂy, 5  104 cells were transferred to agarose-
coated slides which were transferred after lysis to an electrophore-
sis chamber with buffer (300 mM NaOH and 1.0 mM EDTA,
pH > 13). Electrophoresis was conducted under standard condi-
tions (25 V, 300 mA, 1.25 V/cm) for 20 min; subsequently the
slides were neutralized, air-dried and ﬁxed in absolute ethanol.
The slides were stained with ethidium bromide (2.0 lg/mL)
and evaluated under a ﬂuorescence microscope (Axiostar, Zeiss,
Germany) with a magniﬁcation of 40. In all experiments, three
cultures were made in parallel in culture ﬂasks; from each culture,
two slides were made, (total of 6 slides per treatment) and from
each slide 50 cells were analyzed. Comets were scored using the
software Comet Score™ (Sumerduck, VA, USA) and the percentage
of DNA in tail (% DNA in tail) was used as parameter of DNA
damage. All experiments were carried out in agreement with the
guidelines for SCGE assays published by Tice et al. (2000).
2.5. Measurement of glutathione
GSH levels were determined by addition of 5,50-dithio-bis (2-
nitrobenzoic acid) (DTNB), as described by Ellman (1959). DTNB,
a symmetric aryl disulﬁde, reacts with free thiols to form disulﬁde
and 2-nitro-5-thiobenzoic acid; the latter product can be quanti-
ﬁed by its absorbance at 412 nm. The measurements were con-
ducted with a spectrophotometer (Shimadzu, Chelmsford, USA)
and concentration of total proteins was measured as described
by Bradford (1976). Results are expressed as nmol/mg of protein.
2.6. Measurement of intracellular reactive oxygen species
Intracellular ROS levels were estimated using the ﬂuorescent
probe CM-H2DCFDA (Wang and Joseph, 1999). This compound dif-
fuses through the cell membranes and is enzymatically hydrolyzed
by intracellular esterases to form non-ﬂuorescent dichlorodihydro-
ﬂuorescein (Cm-H2DCF), which is oxidized by ROS to ﬂuorescent
dichloroﬂuorescein (CM-DCF). The DCF ﬂuorescence intensity is
proportional to intracellular ROS production and was measured
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485 nm, emission 538 nm). Results are expressed in arbitrary units
(ﬂuorescence intensity).2.7. Measurement of cytochrome c
Cyt-c release was determined according to the protocol of
Sathishkumar et al. (2009). The cytosolic fractions were added to
a 96-well plate that had been pre-coated with rat monoclonal
antibody speciﬁc for Cyt-c and was detected using the horseradish
peroxidase-conjugated (HRP-conjugated) monoclonal secondary
antibody. After removal of the unbound monoclonal antibody-
HRP conjugate, solutions of tetramethylbenzidine and H2O2 were
added to the wells. The reaction was ﬁnished by acidiﬁcation with
HCl, and the extent of chromophore formation was quantiﬁed at
450 nm using a microplate reader (Tecan, Männedorf, Switzer-
land). Results are expressed as ng of Cyt-c/106 cells.2.8. Statistical analysis
All data analyses were performed with the GraphPad Prism 5
software system (La Jolla, CA, USA). All results are expressed as
mean ± standard deviation (SD). Statistical analyses were con-
ducted using one-way ANOVA followed by Dunnett’s test and
was considered signiﬁcative when p was 6 0.05.Fig. 1. Impact of treatment of lutein (LT) (a) and cisplatin (cDDP) (b) on the viability
of HepG2 cells. The cultures were exposed to the compounds for the period of 24 h.
Bars represent means ± SD of results. Per experimental point, three cultures were
made in parallel in different 96 well microplates with eight replicates per
microplate and the viability of the cells was determined by MTT assay as described
in Section 2. ⁄Indicate statistical difference between control group and treated cell
groups (p 6 0.05, one way-ANOVA and Dunnett’s test).3. Results
3.1. Cytotoxicity
Fig. 1a and b show the impact on the viability of the cells after
exposure with different doses of LT and cDDP. It can be seen that
higher doses of the platinum compound decreased the survival of
the cells in a dose dependent manner. After the exposure of the
cells to cDDP, the cellular viability was reduced by 31.7% and
71.2% at higher concentrations (5.0 and 10.0 lM, respectively).
The impact of LT on the survival of the cells is depicted in
Fig. 1a. Also, in this experiment, a clear dose effect was observed.
After treatment of the cells with 50.0 and 100.0 lM of LT, the sur-
vival rate was of 68.9% and of 53.4%, respectively.
Fig. 2 demonstrate the association of the carotenoid with the
platinum compound in pre-, simultaneous and post-treatment
schemes. It can be seen that LT is able to reduce signiﬁcantly the
cDDP-induced cytotoxicity in the cells when the compound was
added before or in combination with the cDDP (10.0 lM) (around
60% of cell viability against approximately 30% found in the groups
which received only cDDP) while no such effect was observed
when the carotenoid was added after the platinum compound.
3.2. Single cell gel electrophoresis assays
The results concerning the impact of the treatment of the cells
with the carotenoid and cDDP on DNA stability are showed in
Fig. 3. Exposure to cDDP reduced the %DNA in tail of the cells by
66.5%, while no evidence of genotoxic effect was seen after the
exposure of the cells to the carotenoid (0.1–10.0 lM) under any
condition of test.
The results of experiments in which the protective properties of
LT on DNA damage induced by cDDP were also investigated and are
summarized in Fig. 4. It is notable that the most pronounced pro-
tective effect of the carotenoid was seen in pre- and simultaneous
treatment, i.e., all doses tested of LT were able to restore the %DNA
in tail to respective negative control levels in both protocols of
treatment. However, no protective effect was seen when the carot-
enoid was added after cDDP, in all concentrations tested.
3.3. Measurement of the biochemical parameters related to redox
status of the cells
Figs. 5–7a–c summarize the results of additional measurements
in which biochemical parameters of the redox status wereFig. 2. Impact of the association cisplatin (cDDP) and lutein (LT) on the viability of
HepG2 cells. LT was added for 24 h before (pre-treatment), during (simultaneous
treatment) or after (post-treatment) treatment with cDDP. (h) control group; (j)
cDDP (10.0 lM); ( ) LT (0.1 lM) + cDDP; ( ) LT (1.0 lM) + cDDP; ( ) LT
(10.0 lM) + cDDP. Bars represent means ± SD of the results. Per experimental point,
three cultures were made in parallel in different 96 well microplates with eight
replicates per microplate and the viability of the cells was determined by MTT assay
as described in Section 2. ⁄Indicate statistical difference between cDDP group and
treated cell groups (p 6 0.05, one way-ANOVA and Dunnett’s test).
Fig. 3. Induction of DNA-migration in HepG2 cells after the treatment with
cisplatin (cDDP) and either lutein (LT). The cells were exposed to the compounds for
three hours. Bars represent means ± SD of results obtained with three independent
cultures per experimental point; from each, two slides were made and for each, 50
cells were analyzed for comet formation. ⁄Indicate statistical difference between
control group and treated cell groups (p 6 0.05, one way-ANOVA and Dunnett’s
test).
Fig. 4. Induction of DNA-migration in HepG2 cells after the treatment with
cisplatin (cDDP) and lutein (LT). The cells were exposed to the cDDP for 3 h. LT was
added for three hours before (pre-treatment), during (simultaneous treatment) or
after (post-treatment) treatment with cDDP. (h) Control group; (j) cDDP (1.0 lM);
) LT (0.1 lM) + cDDP; ( ) LT (1.0 lM) + cDDP; ( ) LT (10.0 lM) + cDDP. Bars
indicate means ± SD of results obtained with three independent cultures per
experimental point; from each, two slides were made and for each, 50 cells were
analyzed for comet formation. ⁄Indicate statistical difference between cDDP treated
group and cells treated with cDDP in addition to LT (p 6 0.05, one way-ANOVA and
Dunnett’s test.
Fig. 5. Impact on glutathione (GSH) levels in HepG2 cells after the exposure to
different concentrations of cisplatin (cDDP) (a); to cDDP (1.0 lM) to several time
period points (b) and cells treated with cDDP (1.0 lM) in addition to different doses
of lutein (LT) (c). Bars indicate means ± SD of results obtained with ﬁve independent
cultures per experimental point. GSH levels were determined spectrophotometri-
cally as described in Section 2. ⁄Indicate statistical difference between control group
and treated cell groups; #indicate statistical difference between cDDP group and
treated cell groups (p 6 0.05, one way-ANOVA and Dunnett’s test).
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and in absence of LT. It can be seen in Fig. 5a and b that cDDP
caused signiﬁcant reduction of the cellular levels of GSH in a dose
and time manner. After co-treatment of the cells with cDDP and
the carotenoid, the GSH levels were restored completely at higher
concentrations of LT (10.0 and 25.0 lM).
The impact of the exposure to cDDP at several concentrations
and times of exposure on intracellular ROS and Cyt-c release is
shown in Figs. 6 and 7a and b, respectively. Exposure of the cells
to cDDP resulted in a signiﬁcant increase of formation of ROS
and Cyt-c release which was attenuated when the cultures were
supplemented with the carotenoid (1.0, 10 and 25 lM) (Figs. 6c
and 7c).
4. Discussion
Many health claims have been made for natural compounds de-
rived from vegetables, fruits and plants. This interest has increased
the number of studies aiming to identify and characterize the bio-
logical effects of the active natural compounds (Veiga Junior et al.,2005). Carotenoids, for instance, absorb excess energy from other
molecules through a non-radiative energy transfer mechanism;
this is possible due to the presence of conjugated double bonds
in their structures (Palozza and Krinsky, 1992) and this character-
istic may be responsible for the antioxidant activity related to
carotenoids (Rao and Rao, 2007) especially by the ability to quench
singlet oxygen molecules (Chaudiere and Ferrari-Iliou, 1999).
It is well documented that high doses of carotenoids induced
cytotoxicity in several laboratorymodels (for review see El-Agamey
et al., 2004). Carotenoids might participate in lipid peroxidation as
pro-oxidants and that one of the key factors in determining the
action of carotenoids as pro-oxidants is the concentration and par-
tial pressure of O2 (Burton and Ingold, 1984; Sujak et al., 1999).
Fig. 6. Impact on reactive oxygen species (ROS) formation in HepG2 cells after the
treatment of different doses of cisplatin (cDDP) (a); to cDDP (1.0 lM) to several
time period points (b) and cells treated with cDDP (1.0 lM) in addition to different
concentrations of lutein (LT) (c). Bars indicate means ± SD of results obtained with
ﬁve independent cultures made in parallel. ROS formation was monitored by use of
ﬂuorometer as described in Section 2. ⁄Indicate statistical difference between
control group and treated cell groups; #indicate statistical difference between cDDP
group and treated cell groups (p 6 0.05, one way-ANOVA and Dunnett’s test).
Fig. 7. Quantiﬁcation of cytochrome-c (Cyt-c) release after exposure of HepG2 cells
to different doses of cisplatin (cDDP) (a); to cDDP (1.0 lM) to several time period
points (b) and cells treated with with cDDP (1.0 lM) in addition to different
concentrations of lutein (LT) (c). Bars indicate means ± SD of results obtained with
ﬁve independent cultures made in parallel. Cyt-c release was determined spectro-
photometrically as described in Section 2. ⁄Indicate statistical difference between
control group and treated cell groups; #indicate statistical difference between cDDP
group and treated cell groups (p 6 0.05, one way-ANOVA and Dunnett’s test).
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that LT (50.0 and 100.0 lM) cause cytotoxicity in a dose dependent
manner.
The absence of genotoxic effects observed in the present study
already was demonstrated previously by several investigations
using different tests systems and concentrations of LT. For exam-
ple, Collins et al. (1998) showed that LT did not alter the pattern
of DNA migration of humans supplemented with LT for the period
of 4 weeks, assessed by SCGE assay in peripheral lymphocytes and
Kruger et al. (2002) ﬁnd no evidence of mutagenic properties of LT
in several strains of Salmonella typhimurium by Ames test in pres-
ence and absence of S9 fraction. However, genotoxic effects of thiscarotenoid was already described, as the ﬁndings of Astley et al.
(2004) which demonstrated that LT was able to increase the comet
formation at 4.0 and 8.0 lM, in cultures of human T leukemia cell
line (MOLT-17).
One of the reasons for the discrepancy may be that the HepG2
cells possess a variety of drug metabolizing enzymes including
those which are involved in the detoxiﬁcation of ROS and reﬂect
the situation in humans better than cell lines that lack these en-
zymes (Knasmuller et al., 1998; Mersch-Sundermann et al.,
2004). Besides this, in general, serum concentrations of LT found
in men after intake of carotenoid rich in foods are in the average
of 3.0 lM (Halliwell and Gutteridge, 2007). The doses of LT used
in the present study reﬂect the real exposure situation in humans,
since the concentrations used in the comet assays ranged between
0.1 and 10.0.
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and was reported based on several results from many methods,
including SCGE assays (Pfuhler and Wolf, 1996). In the present
study, cells exposed to cDDP resulted in a decrease of %DNA in
the tail; these ﬁndings are expected, since Pang et al. (2007) and
Mendonça et al. (2010) have already showed a decrease of comet
formation after the treatment of HCT116 colon retalcancer and
PC12 cells with platinum compounds at similar time of exposure
and concentration of cDDP used in the present study. Toxic effects
of classical platinum compounds are related to the formation of Pt–
DNA or DNA-DNA adducts through the covalent bindings with the
nitrogen-sites of purines present in the DNA (Blommaert et al.,
1995; Rajski and Williams, 1998); induction of either DNA-DNA
or DNA–protein crosslinks reduces the pattern DNA migration
through the agarose gel at any pH (Tice and Strauss, 1995).
For the identiﬁcation of novel candidate chemopreventive
agents, in vitro models are important for the elucidation of their
mechanism of action, i.e., while in vivo experiments give us evi-
dence which is related to the human exposure, it often fails to
establish the possible protective mechanisms involved in the
experiments. The results of the treatment protocols that we em-
ployed in SCGE assays give us evidence of the protective effects
of LT. In pre- and simultaneous treatment, the carotenoid was able
to restore the pattern of DNA migration to those found in the
respective negative controls, but no evidence was reached when
LT was added after the platinum compound. This observation indi-
cates that the reduction of comet formation is either due to extra-
cellular direct scavenging or due to intracellular effects, which may
involve intracellular inactivation of radicals in the cells as well as
induction of enzymes that reduce the redox status (Bertram,
1999; Jewell and O’Brien, 1999; Paiva and Russell, 1999; Riccioni,
2009). Under these conditions, it could be inferred that LT act as
desmutagenic (compounds that act directly on mutagens or their
precursors and inactivate them) agent (Kada and Shimoi, 1987).
The protective effects of LT against DNA-instability induced by
DNA-reactive carcinogens were demonstrated in earlier studies,
in vitro and in vivo. Antimutagenic effects of LT against aﬂatoxin
B1 were demonstrated in S. typhimurium by Ames test, in presence
or in absence of S9 fractions (Gonzalez de Mejia et al., 1997). Horst
et al. (2010) observed a signiﬁcant reduction of comet formation
induced by H2O2 in hepatocytes of rats after the supplementation
with extracts of lutein rich foods.
A completely restoration of the DNA-instability induced by
cDDP exposure in mice treated for the period of 14 days was seen
after the supplementation with the carotenoid (0.2 and 0.5 mg/kg
b.w.) (Serpeloni et al., 2010) at doses which reﬂect the human
exposure. According to Lienau et al. (2003), around 0.2 mg/kg of
b.w. of LT is an appropriate amount for a human to ingest daily.
In a recent study, Sindhu et al. (2010) demonstrated that supple-
mentation of LT can play a role as hepatoprotector against the oxi-
dative damage induced by paracetamol, carbontetrachloride and
ethanol, in vivo. However, the doses used in this study ranged be-
tween 50.0 and 250.0 mg/kg of b.w. and do not absolutely reﬂect
the scenario which humans are usually exposed to the carotenoid
without any supplementation regime.
The fact that no evidence for a protective effect was seen when
the carotenoid was added after the cDDP treatment can be taken as
an indication that the effects of LT do not involve alteration of
DNA-repair processes (De Flora and Ferguson, 2005; Kuroda
et al., 1992). These ﬁndings are in accordance to Santocono et al.
(2006) who demonstrated by use of SCGE assay that the carotenoid
have no inﬂuence on the DNA-repair kinetics, in human neuroblas-
toma and rat trachea epithelial cell cultures after irradiation by
UVA at several times of exposure.
For a better elucidation of the possible protective properties of
the carotenoid, we carried out a number of biochemical measure-ments related to redox status of the cells. The results of these
experiments showed that cells exposed to the dose of 1.0 lM of
cDDP for 3 h (same condition of that used in the SCGE assays
experiments) was able to decrease the GSH levels, induce ROS for-
mation and trigger the release of Cyt-c into the cytoplasm of
HepG2 cells, reinforcing the capacity of cDDP to induce alterations
in the redox status of the cells (for review see Chirino and Pedraza-
Chaverri, 2009).
Reduction of the biochemical alterations induced by cDDP after
the co-treatment of the cells with LT, clearly indicate the antioxi-
dant properties of this carotenoid. Indeed, several studies reported
the antioxidant properties of many carotenoids. Muriach et al.
(2008) demonstrated that LT was able to reestablish the levels of
GSH, which was decreased by exposure to high concentrations of
glucose and Santocono and coworkers (2007) showed a reduction
of RNS induced by nitric oxide formation after the exposure of
the cells to LT in SK-N-SH human neuroblastoma cells. Moreover,
Nakajima et al. (2009) observed a clear reduction of intracellular
ROS formation induced by stauporine when the carotenoid zeaxan-
thin, an analogue of LT, was added before (20 min) of the exposure
to stauporine in cultures of retinal ganglion cells; it was also dem-
onstrated that the sub-acute treatment with LT per se, increased
the levels of GSH and activity of the antioxidant enzyme CAT, in to-
tal blood of mice (Serpeloni et al., 2010).
Cyt-c release is a central step in the initiation of caspase-depen-
dent apoptosis (Scorrano and Korsmeyer, 2003; Tsujimoto and
Shimizu, 2000; Vander Heiden and Thompson, 1999). This may
be due to the fact that a large amount of Ca2+ or ROS is generated
before Cyt-c release, resulting in a subsequent disruption of signal-
ing and mitochondrial functions and the destruction of cellular
components by Ca2+-activated catabolic enzymes and reactive spe-
cies (An et al., 2004). Thus, compounds that are able to reduce ROS
formation are, consequently, able to decrease Cyt-c release and
block apoptosis. There are no data available on the capacity of
carotenoids to prevent Cyt-c release. However, some earlier studies
showed the ability of LT to prevent apoptosis and intracellular Ca2+
levels. For example, LT, at doses of 10.0 and 15.0 lM, reduced sig-
niﬁcantly the apoptosis induced by the micotoxin deoxynivalenol
(DNO) in HT29 cells (Krishnaswamy et al., 2010), parallel to
restoration of the GSH levels and of the activities of antioxidants
enzymes catalase, glutathione-peroxidase and superoxide dismu-
tase, which were also altered by exposition to the DNO.
The protective effects in pre- and simultaneous treatment seen
by use of SCGE assays and also its antioxidant effects, clearly indi-
cate that the carotenoid LT is effective to prevent the adverse ef-
fects induced by cDDP in HepG2 cells and can be a promising
candidate for the use in chemoprevention trials.
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